Evidence map›Paper›PMID 34720793›Full record

ArticleMycological progress2021

Enhanced culturing techniques for the mycobiont isolated from the lichen

Gregor Pichler, Fabio Candotto Carniel, Lucia Muggia, Andreas Holzinger, Mauro Tretiach, Ilse Kranner

Open access · hybridAbstract read
In one paragraph

Article in Mycological progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gregor PichlerDepartment of Botany, University of Innsbruck, Sternwartestraße 15, 6020 Innsbruck, Austria.ORCID 0000-0002-3129-7834
Fabio Candotto CarnielDepartment of Life Sciences, University of Trieste, Via Giorgieri 10, 34127 Trieste, Italy.ORCID https://orcid.org/0000-0002-8277-4725
Lucia MuggiaDepartment of Life Sciences, University of Trieste, Via Giorgieri 10, 34127 Trieste, Italy.ORCID https://orcid.org/0000-0003-0390-6169
Andreas HolzingerDepartment of Botany, University of Innsbruck, Sternwartestraße 15, 6020 Innsbruck, Austria.ORCID https://orcid.org/0000-0002-7745-3978
Mauro TretiachDepartment of Life Sciences, University of Trieste, Via Giorgieri 10, 34127 Trieste, Italy.ORCID https://orcid.org/0000-0002-0529-1359
Ilse KrannerDepartment of Botany, University of Innsbruck, Sternwartestraße 15, 6020 Innsbruck, Austria.ORCID https://orcid.org/0000-0003-4959-9109
Universität Innsbruck · ATUniversity of Trieste · IT

Funding

Austrian Science Fund FWF P 32092
6 · The paper itself

Abstract

Lichens and their isolated symbionts are potentially valuable resources for biotechnological approaches. Especially mycobiont cultures that produce secondary lichen products are receiving increasing attention, but lichen mycobionts are notoriously slow-growing organisms. Sufficient biomass production often represents a limiting factor for scientific and biotechnological investigations, requiring improvement of existing culturing techniques as well as methods for non-invasive assessment of growth. Here, the effects of pH and the supplement of growth media with either D-glucose or three different sugar alcohols that commonly occur in lichens, D-arabitol, D-mannitol and ribitol, on the growth of the axenically cultured mycobiont isolated from the lichen SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11557-021-01707-7.

Indexed as

CultureD-arabitolD-glucoseD-mannitolImage AnalysisRibitol

Identifiers

PMID34720793
PMCPMC8550697
OpenAlexW3167701077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.